Clinical Trials on Pleural Disorder in Australia

Total 4299 results

Monash University

Recruiting

Nut Supplementation to Mitigate Post-stroke Cognitive Decline (NUT-me)

Stroke | Dementia

Australia
Royal Perth Hospital

Recruiting

Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans (EMPA-SNS)

Obesity | Type 2 Diabetes Mellitus | Metabolic Syndrome

Australia
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases

Bone Neoplasms

Australia
The University of New South Wales
Australian Government Department of Health and Ageing

Completed

Multicomponent Risk Factor Intervention for People With a Severe Mental Illness: a Feasibility Study

Behavior, Addictive | Obesity | Psychotic Disorder

Australia
University of Adelaide
Salk Institute for Biological Studies

Terminated

Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? (RESHAPE2)

Insulin Resistance | Type2 Diabetes

Australia
GlaxoSmithKline

Completed

An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

Bipolar Disorder

Australia
AstraZeneca

Completed

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Australia
Medical University Innsbruck
Paracelsus Medical University; Austrian Science Fund (FWF)

Completed

Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder

Schizophrenia | Bipolar I Disorder

Austria
Premier Specialists, Australia

Active, not recruiting

Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo (TILDVIT-1227)

Skin Diseases | Vitiligo | Hypopigmentation | Skin and Connective Tissue Diseases | Pigmentation Disorder | Biologic

Australia
Medical University of Graz

Recruiting

BIPLONG - The Bipolar Disorder in the Longitudinal Course (BIPLONG)

Bipolar Disorder

Austria
Sir Charles Gairdner Hospital

Completed

Short Term Effects of FX Dialysers on QOL and Inflammation

Kidney Failure, Chronic

Australia
Bayer
ImmunoGen and MorphoSys

Completed

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Mesothelioma

Belgium, France, United States, Canada, Spain, Turkey, United Kingdom, Australia, Finland, Italy, Poland, Korea, Republic of, Netherlands, Russian Federation
Melbourne Health

Completed

A Study of Methods to Reduce Anxiety in Preoperative Elective Surgical Patients

Anxiety

Australia
Monash Medical Centre
Monash University

Recruiting

FASST - Fetal Alcohol Spectrum Stimulant Trial (FASST)

Fetal Alcohol Spectrum Disorders

Australia
Murdoch Childrens Research Institute

Recruiting

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC) (MARVEL-PIC)

Neoplasms | Bone Marrow Transplantation

Australia
Turning Point
Monash University; Eastern Health; National Centre for Clinical Research on Emerging...

Recruiting

Intranasal Oxytocin for Methamphetamine Withdrawal in Women (mOXY)

Methamphetamine Use Disorder

Australia
Murdoch Childrens Research Institute

Recruiting

Pilot Study of MC in Paediatric Palliative Care

Palliative Care

Australia
The University of Western Australia
King Edward Memorial Hospital

Completed

The Cycle Study: a Study of the Effectiveness of Cycling Exercise in Breaking the Cycle of Pregnancy Diabetes

Gestational Diabetes Mellitus

Australia
Peter MacCallum Cancer Centre, Australia
Melbourne Health

Completed

NMP in Relapsed / Refractory Myeloma

Multiple Myeloma

Australia
Cognition Therapeutics

Completed

Ascending Dose Study of CT1812 in Healthy Volunteers

Cognitive Impairment

Australia
Sensorion

Completed

Evaluation of the Presence of SENS-401 in the Perilymph

Hearing Loss

Australia
Sonova AG

Completed

Hearing Aid Transmitter Performance Study - SRF-366

Hearing Loss

Australia
Medy-Tox

Completed

Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

Cervical Dystonia

Australia
Hospital de Clinicas de Porto Alegre

Unknown

Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children

Generalized Anxiety Disorder | Social Anxiety Disorder | Separation Anxiety Disorder

United States, Australia, Brazil, Israel
Swinburne University of Technology
University of Copenhagen; Monash University; University of Toronto; University... and other collaborators

Recruiting

Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices (AMETHYST)

Psychotic Disorders | Schizophrenia and Related Disorders | Auditory Hallucination

Australia
Australasian Leukaemia and Lymphoma Group
Merck Sharp & Dohme LLC; Novartis Pharmaceuticals

Unknown

Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia (PInNACLe)

Chronic Myeloid Leukaemia

Australia
Peter MacCallum Cancer Centre, Australia
The Leukemia and Lymphoma Society

Completed

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Lymphoma | Multiple Myeloma

Australia
Parisa Gazerani
The Ministry of Science, Technology and Innovation, Denmark; Migraine Research...

Completed

Ibudilast in the Treatment of Patients With Chronic Migraine. (IBU-003)

Migraine Headache

Australia
Bayside Health

Unknown

A Study of the Effectiveness of Virtual Reality Relaxation Combined With Patient-Controlled Analgesia (PCA) Morphine for Those Undergoing Burn Dressing Changes

Pain | Anxiety

Australia
Aqualung Therapeutics Corp.

Completed

First-In-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALT-100

ARDS, Human

Australia
Sir Charles Gairdner Hospital

Completed

Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients

End Stage Kidney Disease

Australia
Abbott Medical Devices

Recruiting

ConfirmRxTM: Posture and Activity

Syncope | Cryptogenic Stroke

Australia
Turning Point
Monash University; Deakin University

Completed

Can Cognitive-bias Modification Training During Inpatient Alcohol Detoxification Reduce Relapse Rates Post-discharge?

Alcohol Dependence

Australia
University of Melbourne
National Health and Medical Research Council, Australia

Recruiting

WiserAD: The Effect of a Structured Online Intervention on Antidepressant Deprescribing in Primary Care (WiserAD)

Depression

Australia
Takeda

Completed

A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea

Sleep Apnea

Australia
The Queen Elizabeth Hospital

Completed

Trial of Portable Oxygen Cylinders Versus Battery Powered Portable Oxygen Concentrators

COPD

Australia
Royal Perth Hospital
Royal Perth Hospital Medical Research Foundation

Completed

Behavioural Intervention for Dysphagia in Acute Stroke

Dysphagia

Australia
KDL Inc.

Unknown

A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis

End Stage Renal Disease | Hyperphosphatemia

Australia
University of Melbourne
Baxter Healthcare Corporation

Completed

Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane

Delirium | Coronary Artery Bypass | Dementia | Cognition Disorders | Morbidity | Amnesia

Australia
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study of Patients With Major Depressive Disorder and Residual Apathy

Major Depressive Disorder

Mexico, Russian Federation, Australia, Taiwan, Canada
University of Manitoba
University of South Australia

Completed

Impact of Pulse-enriched Foods on Cognitive Function and Cardiometabolic Health in Obese Adults (PULSA-2011)

Obesity

Canada, Australia
The University of Queensland
Johns Hopkins University; Royal Brisbane and Women's Hospital; Queensland University... and other collaborators

Recruiting

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease (TRIP)

Parkinson Disease | Mild Cognitive Impairment | Memory Impairment

Australia
The Queen Elizabeth Hospital

Completed

Safety of Continuous Potassium Chloride Infusion in Critical Care (ASPIC)

Arrhythmias, Cardiac | Hypokalemia

Australia
Medical University of Vienna

Completed

Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity

Gender Identity Disorder

Austria
Bayside Health

Terminated

Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Australia
Medtronic Cardiac Rhythm and Heart Failure

Completed

Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System

Syncope | Recurrent Symptomatic Atrial Fibrillation

Netherlands, Australia, United Kingdom, Belgium, Austria, Russian Federation, Slovakia
University of Adelaide
Salk Institute for Biological Studies; University of South Australia

Completed

Time RestrIcted Feeding For Improving Diabetes Risk (TRIFFID) (TRIFFID)

Obesity | Type2 Diabetes

Australia
Macfarlane Burnet Institute for Medical Research...
St Vincent's Hospital Melbourne

Unknown

The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach (TAP)

Hepatitis C | Drug Abuse, Intravenous

Australia
Novo Nordisk A/S

Completed

Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany, Australia
Royal Adelaide Hospital

Completed

Effects of Sitagliptin on Gastric Emptying, Glycaemia and Blood Pressure in Type 2 Diabetes

Diabetes Mellitus | Gastroparesis

Australia

Clinical Trials on Pleural Disorder in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations